The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kwietniak Matthew R. since 2023.
This trader's CIK number is 1974519.
At the time of last reporting, Kwietniak Matthew R. was the Chief Commercial Officer of Avid Bioservices, Inc.. (stock ticker symbol CDMO).
Also see all insider trading activities at Avid Bioservices, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | CDMO | 0 | $0 | 4,538 | $35,461 | 11,984 | $0 |
2023 | CDMO | 0 | $0 | 5,901 | $71,390 | 15,497 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-10-14 | CDMO | Sale | 119 | 10.15 | 1,207 |
2024-10-11 | CDMO | Option Ex | 335 | .00 | 0 |
2024-10-09 | CDMO | Option Ex | 2,763 | .00 | 0 |
2024-10-10 | CDMO | Sale | 982 | 10.05 | 9,869 |
2024-07-12 | CDMO | Option Ex | 881 | .00 | 0 |
2024-07-15 | CDMO | Sale | 307 | 8.36 | 2,566 |
2024-07-12 | CDMO | Sale | 119 | 8.05 | 957 |
2024-07-11 | CDMO | Option Ex | 335 | .00 | 0 |
2024-07-09 | CDMO | Option Ex | 1,267 | .00 | 0 |
2024-07-10 | CDMO | Sale | 444 | 7.54 | 3,347 |
2024-04-30 | CDMO | Sale | 1,233 | 7.40 | 9,121 |
2024-04-11 | CDMO | Option Ex | 669 | .00 | 0 |
2024-04-09 | CDMO | Option Ex | 2,532 | .00 | 0 |
2024-01-11 | CDMO | Option Ex | 669 | .00 | 0 |
2024-01-12 | CDMO | Sale | 274 | 6.77 | 1,854 |
2024-01-09 | CDMO | Option Ex | 2,533 | .00 | 0 |
2024-01-10 | CDMO | Sale | 1,060 | 6.17 | 6,540 |
2023-10-11 | CDMO | Option Ex | 670 | .00 | 0 |
2023-10-12 | CDMO | Sale | 255 | 9.19 | 2,343 |
2023-10-09 | CDMO | Option Ex | 2,532 | .00 | 0 |
2023-10-10 | CDMO | Sale | 970 | 9.20 | 8,924 |
2023-07-11 | CDMO | Option Ex | 669 | .00 | 0 |
2023-07-12 | CDMO | Sale | 252 | 13.61 | 3,429 |
2023-07-09 | CDMO | Option Ex | 1,261 | .00 | 0 |
2023-07-10 | CDMO | Sale | 477 | 13.77 | 6,568 |
2023-06-28 | CDMO | Option Ex | 10,365 | .00 | 0 |
2023-06-29 | CDMO | Sale | 3,947 | 12.70 | 50,126 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kwietniak Matthew R. (Chief Commercial Officer of Avid Bioservices, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.